Estrofurate
| |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
Chemical and physical data | |
Formula | C24H26O4 |
Molar mass | 378.46084 g/mol |
3D model (JSmol) | |
| |
|
Estrofurate (INN, USAN) (developmental code name AY-11483), also known as 17α-(3-furyl)-estra-1,3,5(10),7-tetraene-3,17-diol 3-acetate, is a synthetic, steroidal estrogen that was synthesized in 1967 and studied in the late 1960s and early 1970s but was never marketed.[1][2] It is a relatively weak estrogen in bioassays.[3]
References
- ↑ J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. p. 503. ISBN 978-1-4757-2085-3.
- ↑ Banik, U. K.; Revesz, C.; Herr, F. (1969). "ORALLY ACTIVE OESTROGENS AND PROGESTINS IN PREVENTION OF PREGNANCY IN RATS". Reproduction. 18 (3): 509–515. doi:10.1530/jrf.0.0180509. ISSN 1470-1626.
- ↑ Revesz, C.; Banik, U. K.; Lefebvre, Y. (1970). "AY-11483, A NEW TYPE OF ORALLY ACTIVE OESTROGEN". Reproduction. 22 (1): 27–32. doi:10.1530/jrf.0.0220027. ISSN 1470-1626.
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.